PROFUSA Change in Accounts Payable 2022-2021 | PFSA
PROFUSA change in accounts payable from 2022 to 2021. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
| PROFUSA Annual Change in Accounts Payable (Millions of US $) |
|---|
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.003B | $0.000B |
| Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.099B | 58.65 |
| Tempus AI (TEM) | United States | $13.629B | 0.00 |
| Doximity (DOCS) | United States | $12.349B | 54.94 |
| Hims & Hers Health (HIMS) | United States | $10.193B | 83.52 |
| IRhythm Technologies (IRTC) | United States | $5.074B | 0.00 |
| Hinge Health (HNGE) | United States | $4.605B | 0.00 |
| Privia Health (PRVA) | United States | $2.623B | 194.27 |
| Inspire Medical Systems (INSP) | United States | $2.613B | 38.41 |
| Heartflow (HTFL) | $2.433B | 0.00 | |
| Phreesia (PHR) | United States | $1.732B | 0.00 |
| Enovis (ENOV) | United States | $1.689B | 8.93 |
| 10x Genomics (TXG) | United States | $1.676B | 0.00 |
| Schrodinger (SDGR) | United States | $1.476B | 0.00 |
| Omnicell (OMCL) | United States | $1.452B | 27.97 |
| Azenta (AZTA) | United States | $1.394B | 60.84 |
| Clover Health Investments (CLOV) | United States | $1.338B | 0.00 |
| Claritev (CTEV) | United States | $1.189B | 0.00 |
| Evolent Health (EVH) | United States | $1.059B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.659B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.630B | 0.00 |
| Veradigm (MDRX) | United States | $0.503B | 0.00 |
| Standard BioTools (LAB) | United States | $0.482B | 0.00 |
| Talkspace (TALK) | United States | $0.435B | 130.00 |
| Butterfly Network (BFLY) | United States | $0.363B | 0.00 |
| Carlsmed (CARL) | $0.349B | 0.00 | |
| TruBridge (TBRG) | United States | $0.290B | 50.90 |
| Outset Medical (OM) | United States | $0.243B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.236B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.224B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.211B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.195B | 0.00 |
| CapsoVision (CV) | United States | $0.187B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.141B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.117B | 0.00 |
| CareCloud (CCLD) | United States | $0.115B | 5.23 |
| EUDA Health Holdings (EUDA) | Singapore | $0.098B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.062B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.041B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.023B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.019B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.005B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |